EN
3 Asian Stocks Estimated To Be 26.3% To 39.8% Below Intrinsic Value
As the Asian markets navigate through a period marked by volatility driven by AI investment concerns and fluctuating oil prices, investors are keenly observing opportunities for value amidst the uncertainty. In such an environment, identifying stocks that are trading below their intrinsic value can be a strategic move, offering potential for growth as market conditions stabilize.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Thai Credit Bank (SET:CREDIT) | THB23.70 | THB45.72 | 48.2% |
| Smartsens Technology (Shanghai) (SHSE:688213) | CN¥104.70 | CN¥55.93 | -87.2% |
| P&H Tech (KOSDAQ:A239890) | ₩3120.00 | ₩6201.00 | 49.7% |
| PAL GROUP Holdings (TSE:2726) | ¥1467.00 | ¥2902.59 | 49.5% |
| Nissei ASB Machine (TSE:6284) | ¥8120.00 | ¥15727.08 | 48.4% |
| Natural Food International Holding (SEHK:1837) | HK$1.38 | HK$2.80 | 50.7% |
| Kissei Pharmaceutical (TSE:4547) | ¥3780.00 | ¥7679.17 | 50.8% |
| Kingnet Network (SZSE:002517) | CN¥15.14 | CN¥30.70 | 50.7% |
| Henan Mingtai Al.IndustrialLtd (SHSE:601677) | CN¥14.46 | CN¥28.04 | 48.4% |
| ENN Energy Holdings (SEHK:2688) | HK$48.48 | HK$97.34 | 50.2% |
Let's explore several standout options from the results in the screener.
Protec (KOSDAQ:A053610)
Overview: Protec Co., Ltd. is a South Korean company that manufactures and sells semiconductor packaging equipment and automated pneumatic parts, with a market cap of ₩589.50 billion.
Operations: The company's revenue segments include investment at ₩171.61 million and system department outside at ₩318.17 million.
Estimated Discount To Fair Value: 34.6%
Protec Co., Ltd. is trading at ₩65,500, significantly below its estimated future cash flow value of ₩100,137.3, representing a 34.6% discount to fair value. Despite recent strong earnings growth—net income surged from ₩9 billion to ₩35.09 billion in Q2 2026—future earnings are expected to decline by 5.9% annually over the next three years with revenue growth lagging behind the Korean market at 8.8% per year amidst high share price volatility.
- Insights from our recent growth report point to a promising forecast for Protec's business outlook.
- Get an in-depth perspective on Protec's balance sheet by reading our health report here.
VITZROCELLLtd (KOSDAQ:A082920)
Overview: VITZROCELL Co., Ltd. is a South Korean company that produces and sells lithium batteries, with a market cap of ₩1.07 trillion.
Operations: The company's revenue is primarily derived from its Battery Business segment, which generated ₩277.06 billion.
Estimated Discount To Fair Value: 39.8%
VITZROCELL Co., Ltd. is trading at ₩23,850, well below its estimated future cash flow value of ₩39,618.5, indicating a substantial undervaluation by over 20%. Recent earnings results show strong growth with Q2 net income rising from ₩10.16 billion to ₩17.30 billion year-over-year. Although earnings and revenue are forecast to grow at 16.9% annually—slower than the Korean market—analysts agree on a potential 77.5% stock price increase despite recent share price volatility.
- Our comprehensive growth report raises the possibility that VITZROCELLLtd is poised for substantial financial growth.
- Click to explore a detailed breakdown of our findings in VITZROCELLLtd's balance sheet health report.
Zhejiang Runtu (SZSE:002440)
Overview: Zhejiang Runtu Co., Ltd. is involved in the production and sale of dyes both in China and internationally, with a market cap of CN¥11.99 billion.
Operations: The company's revenue is primarily derived from its Specialty Chemical segment, which generated CN¥6.25 billion.
Estimated Discount To Fair Value: 26.3%
Zhejiang Runtu Co., Ltd. is trading at CN¥10.84, significantly below its estimated future cash flow value of CN¥14.7, highlighting a potential undervaluation by over 20%. Recent earnings results for the nine months ended September 2026 show net income surged to CN¥953.69 million from CN¥225.05 million year-over-year, with sales increasing to CN¥5.52 billion from CN¥4.16 billion, despite slower forecasted revenue and earnings growth compared to the Chinese market averages.
- Our growth report here indicates Zhejiang Runtu may be poised for an improving outlook.
- Click here and access our complete balance sheet health report to understand the dynamics of Zhejiang Runtu.
Key Takeaways
- Take a closer look at our Undervalued Asian Stocks Based On Cash Flows list of 184 companies by clicking here.
- Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
- Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Ready For A Different Approach?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com